Allergen detection
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
153
NCT04909723
Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 2, 2021
Completion: Apr 6, 2023
Loading map...